SHENKMAN CAPITAL MANAGEMENT INC Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$1.5T

Holdings

118

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (118 positions)

#StockSharesValue% PortfolioType
101
IONS 0.125 12/15/24IONIS PHARMACEUTICALS INC
4,903,000$4.4B0.30%
102
LMCA 1.375 10/15/23LIBERTY MEDIA CORP DEL
2,540,000$3.9B0.26%
103
AEO 3.75 04/15/25AMERICAN EAGLE OUTFITTERS IN
1,154,000$3.5B0.24%
104
RGENREPLIGEN CORP
1,463,000$3.4B0.23%
105
STWD 4.375 04/01/23STARWOOD PPTY TR INC
3,053,000$3.2B0.22%
106
EYE 2.5 05/15/25NATIONAL VISION HLDGS INC
1,950,000$3.2B0.22%
107
BMRN 1.25 05/15/27BIOMARIN PHARMACEUTICAL INC
2,879,000$3.0B0.21%
1082,327,000$2.9B0.19%
1091,524,000$2.7B0.18%
110
IQ 2 04/01/25IQIYI INC
3,063,000$2.2B0.15%
111
NOBLE CORP NEW
73,292$1.8B0.12%
1121,161,000$1.7B0.12%
113
ON SEMICONDUCTOR CORP
395,000$1.3B0.09%
114579,000$1.3B0.09%
115
RCL 4.25 06/15/23ROYAL CARIBBEAN GROUP
798,000$1.0B0.07%
116708,000$701.0M0.05%
117
EXASEXACT SCIENCES CORP
305,000$396.0M0.03%
118
BL 0.125 08/01/24BLACKLINE INC
193,000$292.0M0.02%
PreviousPage 2 of 2